Home > Insider Trading > Filing (0001209191-16-130107)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Paratek Pharmaceuticals Inc.	PRTK	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1623720	J. Richard Lim	C/O Paratek Pharmacuticals, Inc. 75 Kneeland Street Boston MA 02111		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-27	384,615	$13.00	779,802	No	4	P	Indirect	By Omega Fund IV, L.P.
Common Stock	Acquisiton	2016-06-27	76,923	$13.00	1,187,365	No	4	P	Indirect	By Omega Fund III, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Omega Fund IV, L.P.
No	4	P	Indirect	By Omega Fund III, L.P.

Footnotes

These securities are held in the name of Omega Fund IV, L.P. ("Omega IV"). The Reporting Person is a director of Omega Fund IV GP Manager, Ltd., the general partner of Omega Fund IV GP, L.P., which is the general partner of Omega IV, and has shared voting and investment power over, and a proportionate pecuniary interest in, the shares held by Omega IV. The Reporting Person disclaims beneficial ownership of the securities held by Omega IV except to the extent of his proportionate pecuniary interest therein.
These securities are held in the name of Omega Fund III, LP. ("Omega III"). Omega Fund III GP, L.P. ("Omega III GP LP") is the general partner of Omega III. Omega Fund III G.P., Ltd. ("Omega III GP") is the general partner of Omega III GP LP. Clessidra, LLC ("Clessidra") is the sole shareholder of Omega III GP. Omega III, Omega III GP LP, Omega III GP, Clessidra, Danish BV and Danish BV GP are collectively referred to as the "Omega Funds". As a result of an understanding relating to the Omega Funds, the Reporting Person may have an indirect pecuniary interest in the securities held by Omega III. The Reporting Person disclaims beneficial ownership of the securities held by Omega III except to the extent of his pecuniary interest therein.